Free Trial

Core Scientific (CORZZ) 10K Form and Latest SEC Filings 2026

Core Scientific logo
$23.94 +1.22 (+5.37%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$24.00 +0.06 (+0.26%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Core Scientific SEC Filings & Recent Activity

Core Scientific (NASDAQ:CORZZ) has submitted 409+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Core Scientific's financial statements. The most recent filing was a Form 4 submitted on May 13, 2026.

Form 4
Core Scientific, Inc./tx Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Core Scientific Files Current Report on May. 6, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Core Scientific Files Quarterly Report on May. 6, 2026

The 10-Q contains Core Scientific's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Core Scientific SEC Filing History

Browse Core Scientific's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/13/2026 3:06 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:03 PM
Core Scientific (1839341) Issuer
Ray Jorge L. (2123780) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/06/2026 3:54 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 3:15 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 3:02 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 6:52 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 11:56 AM
Core Scientific (1839341) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/27/2026 4:30 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2026 7:59 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/22/2026 3:01 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2026 6:36 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 7:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/15/2026 3:02 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 3:32 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:25 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:26 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:44 PM
Core Scientific (1839341) Subject
DUCHENE TODD M (1248745) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2026 3:59 PM
Core Scientific (1839341) Filer
Form DEFA14A
03/31/2026 4:01 PM
Core Scientific (1839341) Filer
Form ARS
03/31/2026 3:55 PM
Core Scientific (1839341) Filer
Form DEF 14A
03/27/2026 5:45 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4/A
03/26/2026 4:39 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 7:29 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2026 7:39 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/19/2026 3:06 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2026 4:14 PM
Core Scientific (1839341) Filer
Form 10-K/A
03/12/2026 11:55 AM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
03/10/2026 3:08 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:13 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 8:05 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/02/2026 3:44 PM
Core Scientific (1839341) Filer
Form 10-Q/A
03/02/2026 3:18 PM
Core Scientific (1839341) Filer
Form 10-K/A
02/19/2026 8:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
02/19/2026 10:56 AM
Core Scientific (1839341) Filer
Form 8-K/A
02/18/2026 4:16 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 10:11 AM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
02/09/2026 5:08 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (Ad)

Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth. Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing.tc pixel

Click here to see the full details before May 15
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
CRAIN ELIZABETH (1604659) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Levy Jordan (1541436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Booth Jeffrey David (2009493) Reporting
Core Scientific (1839341) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 3:15 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 8:07 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
01/07/2026 1:59 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
01/02/2026 5:26 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 7:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
12/10/2025 5:12 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
12/01/2025 7:04 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/17/2025 5:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/13/2025 4:42 PM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G/A
11/12/2025 3:05 PM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
10/31/2025 4:16 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
10/31/2025 3:27 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 3:18 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 9:55 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 9:28 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/24/2025 3:14 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2025 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 4:20 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/22/2025 3:44 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 3:44 PM
Core Scientific (1839341) Subject
Form 425
10/21/2025 4:22 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/17/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/17/2025 5:09 AM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/16/2025 4:22 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/15/2025 3:45 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2025 3:48 PM
Core Scientific (1839341) Subject
Form 425
10/14/2025 4:50 PM
Core Scientific (1839341) Subject
Situational Awareness LP (2045724) Filed by
Form SCHEDULE 13D/A
10/14/2025 7:30 AM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/10/2025 7:48 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2025 7:55 PM
Core Scientific (1839341) Subject
Form 425
10/10/2025 4:27 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/10/2025 4:02 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/09/2025 6:39 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
10/07/2025 4:27 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/07/2025 4:27 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/07/2025 4:23 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/07/2025 4:24 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
09/29/2025 9:06 AM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
09/29/2025 7:00 AM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DEFC14A
09/26/2025 4:26 PM
Core Scientific (1839341) Filer
Form DEFM14A
08/14/2025 9:29 AM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G
08/08/2025 8:40 AM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D
07/29/2025 10:21 AM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

07/16/2025 6:02 PM
BlackRock, Inc. (2012383) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
07/14/2025 4:10 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/14/2025 4:10 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/14/2025 4:12 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/09/2025 4:02 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/08/2025 4:22 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/08/2025 5:09 AM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/07/2025 4:23 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
07/07/2025 4:24 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
(Data available from 1/1/2016 forward)

Core Scientific SEC Filings - Frequently Asked Questions

Core Scientific (CORZZ) has submitted 409+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 4 submitted on May 13, 2026. This was an insider ownership change filed by 4 - Core Scientific, Inc./tx (0001839341) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:CORZZ) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners